• 1
    Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985; 66: 848858.
  • 2
    Murphy SB. Pediatric lymphomas: recent advances and commentary on Ki-1 positive anaplastic large-cell lymphomas of childhood. Ann Oncol. 1994; 5: 5153.
  • 3
    Wright D, Mc Keever P, Carter R. Childhood non-Hodgkin's lymphomas in the United Kingdom: findings from the UK Children's Cancer Study. J Clin Pathol. 1997; 50: 128134.
  • 4
    Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994; 84: 13611392.
  • 5
    Delsol G, Al Saati T, Gatter C, et al. Coexpression of epithelial membrane antigen (EMA), Ki-1 and interleukin-2 receptor by anaplastic large cell lymphomas: diagnostic value in so-called malignant histiocytosis. Am J Pathol. 1988; 130: 5970.
  • 6
    Rimokh R, Maugaud JP, Berger F, et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (Ki-1 lymphoma). Br J Haematol. 1989; 71: 3136.
  • 7
    Kaneko Y, Frizzera G, Edamura S, et al. A novel translocation t(2;5) (p25;q35) in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood. 1989; 73: 806813.
  • 8
    Mason DY, Bastard C, Rimokh R, et al. CD30-positive large cell lymphomas (Ki-1 lymphoma) are associated with a chromosomal translocation involving 5q35. Br J Haematol. 1990; 74: 161168.
  • 9
    Morris SW, Kirsten MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science. 1994; 263: 12811284.
  • 10
    Fujimoto J, Shiota M, Iwahara T, et al. Characterization of the transforming activity of p80 a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc Natl Acad Sci USA. 1996; 93: 41814186.
  • 11
    Bischof D, Pulford K, Mason DY, Morris SW. Role of nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma associated NPM-anaplastic kinase fusion protein in oncogenesis. Mol Cell Biol. 1997; 176: 23122325.
  • 12
    Kuefer MU, Look AT, Pulford K, et al. Retrovirus mediated transfer of the NPM-ALK causes lymphoid malignancy in mice. Blood. 1997; 90: 29012910.
  • 13
    Shiota M, Fujimoto J, Takenaga M, et al. Diagnosis of t(2;5) (p25;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood. 1994; 84: 36483652.
  • 14
    Pulford K, Lamant L, Morris S, et al. Detection of ALK and NPM-ALK protein in normal and neoplastic cells with the monoclonal antibody ALK 1. Blood. 1997; 89: 13941404.
  • 15
    RiesLAG, SmithMA, GurneyJG, et al. editors. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD: National Institutes of Health; 1999.
  • 16
    Weidmann C, Black RJ, Masuyer E, Parkin DM. Incidence of non-Hodgkin's lymphoma in children between 1970 and 1990 in nine European countries. Eur J Cancer. 1999; 35: 12351237.
  • 17
    Wagner HP, Dingeldein-Bettler I, Berchthold W, et al. Childhood NHL in Switzerland: incidence and survival of 120 study and 42 non-study patients. Med Pediatr Oncol. 1995; 24: 281286.
  • 18
    Marky I, Schmiegelow K, Perkkiö M, et al. Childhood non-Hodgkin's lymphoma in the five Nordic countries. J Pediatr Hematol Oncol. 1995; 17: 163166.
  • 19
    Bair V, Birch JM. Patterns and temporal trends in the incidence of malignant disease in children. I. Leukemia and lymphoma. Eur J Cancer. 1994;30A: 14901498.
  • 20
    Coebergh JWW, van der Does-van den Berg A, Kamps WA, Rammeloo JA, Valkenburg HA, van Wering ER. Malignant lymphomas in children in the Netherlands in the period 1973–1985: incidence in relation to leukemia: a report from the Dutch childhood leukemia study group. Med Pediatr Oncol. 1991; 19: 169174.
  • 21
    Samuelsson BO, Ridell B, Röckert L, Gustafsson G, Marky I. Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in Western Sweden. J Pediatr Hematol Oncol. 1999; 21: 103110.
  • 22
    Kadin ME, Sako D, Berliner N, et al. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood. 1986; 68: 10421049.
  • 23
    Greer JP, Kinney MC, Collins RD, et al. Clinical features of 31 patients with anaplastic large cell lymphoma. J Clin Oncol. 1991; 9: 539547.
  • 24
    Sandlund JT, Pui CP, Santana VM, et al. Clinical features and treatment outcome for children with CD30+ large cell non-Hodgkin's lymphoma. J Clin Oncol. 1994; 12: 895898.
  • 25
    Brugières L, Le Deley MC, Pacquement H, et al. CD30+ anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood. 1998; 92: 35913598.
  • 26
    Reiter A, Schrappe M, Tiemann M, et al. Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster Group studies. J Clin Oncol. 1994; 12: 899908.
  • 27
    Massimino M, Gasparini M, Giardini R. Ki-1 (CD 30) anaplastic large-cell lymphoma in children. Ann Oncol. 1995; 6: 915920.
  • 28
    Mora J, Filippa DA, Thaler HT, Polyak T, Cranor ML, Wollner N. Large cell non-Hodgkin lymphoma of childhood: analysis of 78 consecutive patients enrolled in 2 consecutive protocols at the Memorial Sloan-Kettering Cancer Center. Cancer. 2000; 88: 186197.
  • 29
    The Non-Hodgkin's Lymphoma Classification Project. The National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: summary and description of working formulation for clinical usage. Cancer. 1982; 49: 21122135.
  • 30
    Rubie H, Gladieff L, Robert A, et al. Childhood anaplastic large cell lymphoma Ki-1/CD30: clinicopathologic features of 19 cases. Med Pediatr Oncol. 1994; 22: 155161.
  • 31
    Shiota M, Nakanura S, Ichinohasama R, et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood. 1995; 86: 19541960.
  • 32
    Lamant L, Meggetto F, Al Saati T,et al. High incidence of the t(2;5) (p25;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and the P-80 immunostaining. Blood. 1996;87: 284291.
  • 33
    Nakagawa A, Nakamura S, Ito M, Shiota M, Mori S, Suchi T. CD30-positive anaplastic large cell lymphoma in childhood: expression of p80NPM/ALK and absence of Epstein-Barr virus. Mod Pathol. 1997; 10: 210215.
  • 34
    Hutchison RE, Banki K, Shuster JJ, et al. Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood. Ann Oncol. 1997; 8(suppl 1): S37S42.
  • 35
    Chou WC, Su IJ, Tien HF, et al. Clinicopathologic, cytogenetic and molecular studies of 13 Chinese patients with Ki-1 anaplastic large cell lymphoma. Special emphasis on the tumor response to 13-cis retinoic acid. Cancer. 1996;78: 18051812.
  • 36
    Lee SC, Kueh YK, Lehnert M, Chong SM, Tan YO, Wong J. Characteristics and prognosis of Ki-1 positive anaplastic large cell lymphoma in Asians. Aust N Z J Med. 1998; 28: 790794.
  • 37
    Stiller CA, Parkin DM. International variations in the incidence of childhood lymphomas. Paediatr Perinat Epidemiol. 1990; 4: 303324.
  • 38
    Shih L-Y, Liang D-C. Non-Hodgkin's lymphoma in Asia. Hematol Oncol Clin North Am. 1991; 5: 9831001.
  • 39
    Herrinton LJ, Goldoft M, Schwartz SM, Weiss NS. The incidence of non-Hodgkin's lymphoma and its histologic subtypes in Asian migrants to the United States and their descendents. Cancer Causes Control. 1996; 7: 224230.
  • 40
    Kaplinsky C, Toren A, Neumann Y, et al. Central nervous system involvement at diagnosis in a case of pediatric CD30+ anaplastic large cell lymphoma. Med Pediatr Oncol. 1997; 28: 132135.
  • 41
    Abdulkader I, Cameselle-Teijeiro J, Fraga M, Rodriguez-Núnez A, Allut AG, Forteza J. Primary anaplastic large cell lymphoma of the central nervous system. Hum Pathol. 1999; 30: 978981.
  • 42
    Vecchi V, Burnelli R, Pileri S, et al. Anaplastic large cell lymphoma (Ki-1/CD30+) in childhood. Med Pediatr Oncol. 1993; 21: 402410.